Key Sessions
Andreas Laustsen
Using Monoclonal Antibodies as Antivenom
Technical University of Denmark
Nicole Borth
KEYNOTE: Heterogeneity and What Makes a Phenotype
BOKU University and Austrian Center of Industrial Biotechnology (ACIB)
keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Day One - CET/CEST (Cent Europe Summer, GMT+2)
keyboard_arrow_leftSearch & Filter
search
Streams
Day One - CET/CEST (Cent Europe Summer, GMT+2)
search
Streams
08:00 - 08:55
Welcome Coffee and Registration
Showing 5 of 5 Streams
Cell Line Development & Engineering
Cell Culture & Upstream Processing
Recovery & Purification
Manufacturing Strategy & Bioprocessing 4.0
Cell and Gene Therapy Manufacturing
08:55 - 09:00
Chairperson's Opening Remarks
09:00 - 09:30
KEYNOTE: Heterogeneity and What Makes a Phenotype
- Nicole Borth - Department of Biotechnology, , BOKU University and Austrian Center of Industrial Biotechnology (ACIB)
09:30 - 10:00
Label-Free LC-MS/MS Characterization of the Ubiquitin-Modified Proteome of Recombinant Chinese Hamster Ovary Cells in Response to ER-Stress in Bioprocess-Relevant Conditions
- Paula Meleady - Associate Professor, School of Biotechnology, Dublin City University
10:00 - 10:30
Scientific Showcase by Asimov
08:55 - 09:00
Chairperson Opening Remarks
09:00 - 09:30
Guidelines and Suggested Workflow of AI and ML Implementation
- Sakis Mantalaris - Professor, Trinity College Dublin
09:30 - 10:00
Implementation of Automated Manufacturing and Advanced Sensoring
- Karoline Bechtold-Peters - Director, Science & Technology, Novartis
10:00 - 10:30
Scientific Showcase by Repligen
08:55 - 09:00
Chairperson's Opening Remarks
09:00 - 09:30
A Review of Supports for Adsorptive Separations of Biomolecules
- Thomas Ransohoff, MS - Principal, RTI Consulting, Inc.
09:30 - 10:00
Next Generation Downstream Process Development and Manufacturing
- Fabian Vogt - Head of Laboratory, Protein Science, Boehringer Ingelheim Pharma GmbH & Co. KG
10:00 - 10:30
Scientific Track Presentation
08:55 - 09:00
Chair’s Welcome Remarks
- Jose Ortiz Tena - Manager Lead Bioprocess Optimization, Roche
09:00 - 09:30
Deploying Modeling & Simulation to Enable Advanced Process Monitoring & Control
- Johannes Scheiblauer - Head of Automation & Control (R&D PharmSci), Takeda
09:30 - 10:00
Paradigm shift in Biologics manufacturing – to cope with challenges in New Biologics Modality manufacturing
- Uwe Buecheler - Senior Advisor Biopharmaceuticals and Former SVP, Head of Business Unit Biopharmaceuticals, Boehringer Ingelheim
10:00 - 10:30
Scientific Track Presentation (Sponsor)
08:55 - 09:00
Chair’s Welcome Remarks
- Volker Huppert - Chief Development Officer, Glycostem Therapeutics
09:00 - 09:30
Developing ATMPs for commercialization: A large Pharma process approach from idea to a manufactured Cell Therapy product
- Michael Delahaye - Director, Team Leader Cell Therapy Bioprocessing, AstraZeneca
09:30 - 10:00
VSV-GP process development
- Michaela Smolle - Principal Scientist, Bioprocess Innovation Team, ViraTherapeutics
10:00 - 10:30
Scientific Track Presentation (Sponsor)
10:30 - 11:15
Morning Break
Showing 5 of 5 Streams
Cell Line Development & Engineering
Cell Culture & Upstream Processing
Recovery & Purification
Manufacturing Strategy & Bioprocessing 4.0
Cell and Gene Therapy Manufacturing
11:15 - 11:45
KEYNOTE: Engineering The Lipidome To Improve Productivity
- James Budge - Postdoctoral Research Fellow, University of Kent
11:45 - 12:15
Adjusting Glycosylation of Cell Lines
- Emilia McLaughlin, PhD - Founder, kyron.bio
12:15 - 12:45
Scientific Showcase by 908 Devices
11:15 - 11:45
Transfer Learning and Real-time Architectures of Digital Twins
- Christoph Herwig - Founder, Lisalis GmbH
11:45 - 12:15
Digital Twins Using Real-Time and Genome Data
- Dong-Yup Lee, Ph.D. - Assistant Professor / Senior Scientist, Chemical and Biomolecular Engineering, National University of Singapore / Bioprocessing Technology Institute
12:15 - 12:45
Scientific Showcase by Sartorius
11:15 - 11:45
Digital Twins and Hybrid Models for Bioprocess Intensification and Optimization
- Krist V. Gernaey - Professor, Technical Univirtsity of Denmark
11:45 - 12:15
Application of Modelling Tech in BLA
- Joey Studts, Ph.D. - Director, Late Stage Purification Development, Boehringer Ingelheim Pharma GmbH & Co. KG
12:15 - 12:45
Scientific Track Presentation
11:15 - 11:45
Bioprocessing strategies for multi-national trials: Streamlining clinical success through bioprocess decision-making
- Ben Weil - Head of CMC for Advanced Therapies Bioprocessing, INmuneBio
11:45 - 12:15
Using analytics to support AAV manufacturing strategies
- Elena Dominguez-Vega - Senior Researcher, Center for proteomics and metabolomics, Leiden University Medical Center
12:15 - 12:45
Scientific Track Presentation (Sponsor)
11:15 - 11:45
Applying continuous integrated processing for cell and gene therapies
- Manuel Carrondo - Vice-President, Instituto de Biologia Experimental e Tecnológica
11:45 - 12:15
Key considerations for establishing a virtual stem cell therapy platform
- Ricardo Baptista - CTO, Alder Therapeutics
12:15 - 12:45
Scientific Track Presentation (Sponsor)
12:45 - 14:15
Grand Opening of the Exhibition Hall and Lunch
Showing 5 of 5 Streams
Cell Line Development & Engineering
Cell Culture & Upstream Processing
Recovery & Purification
Manufacturing Strategy & Bioprocessing 4.0
Cell and Gene Therapy Manufacturing
14:15 - 14:45
Genetic Sequences – Which ones are important and why for CHO improvement
- Mauro Torres Sebastian - Research Associate, University of Manchester
14:45 - 15:15
KEYNOTE: CLD Strategies for Efficient Production
- Robyn Emmins - Scientific Director, Cell Line Development, GSK
15:15 - 15:45
Scientific Showcase by Beckman Coulter
14:15 - 14:45
New Cell Culture Analyser Technology at Large Scale: Case study of implementation, issues and resolution
- Gearóid Duane - Principal Scientist, Manufacturing Science & Technology Upstream, Bristol Myers Squibb, Cruiserath Biologics
14:45 - 15:15
Raman-based monitoring of the amino acids and the antibody N-glycosylation in high cell density steady-state perfusion culture
- Veronique Chotteau, PhD - Professor in mammalian-based bioprocessing, KTH - Royal Institute of Technology
15:15 - 15:45
Scientific Showcase by Merck
14:15 - 14:45
ML Driven Controls for Bioprocessing
- Massimo Morbidelli - Professor, Department of Chemistry and Applied Biosciences, ETH Zurich
14:45 - 15:15
CSL112 Process Characterization: A Modern Process Development Approach Implementing QbD Principles
- Dominique Zemp - Scientist Process Development, CSL
14:15 - 14:45
Cell-free alternative for the production of highly potent neurotoxins: An Economic assessment
- Williams Olughu - Senior Principal Scientist, Ipsen
14:45 - 15:15
Downstream processing for next generation therapeutic manufacturing
- David O'Connell - Lecturer in Biotherapeutics, School of Biomolecular & Biomedical Science, University College Dublin
15:15 - 15:45
Scientific Track Presentation (Sponsor)
14:15 - 14:45
AAV downstream innovation trends
- Elise Huang - Group Lead, Gene Therapy Drug Substance Process Science Downstream, UCB
14:45 - 15:15
Expanding the manufacturing solutions for cell and gene therapies
- Adam Brown, Ph.D. - Associate Professor, University of Sheffield
15:15 - 15:45
Scientific Track Presentation (Sponsor)
15:45 - 16:30
Afternoon Break in Exhibition Hall
Showing 1 of 1 Streams
Keynote Plenary
16:30 - 16:35
Chairperson's Remarks
16:35 - 17:10
Using Monoclonal Antibodies as Antivenom
- Andreas Laustsen - Center Director & Professor, Technical University of Denmark
17:10 - 17:45
Plenary Keynote by Asahi Kasei
17:45 - 19:00
Cocktail Reception in Exhibit & Poster Hall
Get the Latest Event Updates
Sign up to get the latest event updates and information.
Filter
Streams